1Mcdonald WI,compston A,Edan G,et al.Rocommended diagnostic criteria for mutiple sclerosis: guidelines from the international panel on the diagnosis of mutiple sclerose[J].Ann Neural,2001,50(1):121-127.
2Barkholf F,Filippi M,Miller DH,et al.Compasion of MRI criteria at first presentation to predict conversion to clinically definite mutiple sclerosis[J].Brain,1997,120(Pt 11):2059-2069.
3Brex PA,Miszkiel KA,O'Piordan JI,et al.Assessing the risis of early mutiple sclerosis in patients with clinically isolated syndromes:the role of a follow up MRI[J].J Neurol Neurosurg Psychiatry,1998,64(suppl 1):44-46.
4Sastre-Garriga J,Tintore I,Rovira A,et al.Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem:cra-nical magnetic resonance imgine,cerebrospinal fluid and neurophysiological findings[J].Mult Scler,2003,9(1):39-43.
5Morrissey SP,Miller DH,Kendall BE,et al.The significance of brain magnetic resonance imgine abnormalities at presentation with clinically isolated symdromes suggestive of multiple sclerosis.a 5-year follow-up study[J].Brain,1993,116(Pt 2):135-146.
6Tintere I,Rovia A,Rio J,et al.New diagnosistic critera for multiple sclerosis:application in first demyelinating epsode[J].Neurology,2003,14,60(1):6-7.
7Fischer JS,Rudick RA,Cutter GR,et al.The Mutiple Sclerosis Functional Composite Measure (MSFC):an integrated approach to MS clinical outcome assessment.National MS Society Clinical Outcomes Assement Task Force[J].Mult Scler,1999,5(4):244-250.
8Kalkers NF,Bergers L,de Groot V,et al.Concurrent validity of the MS functional commposite using MRI as a biological disease maker[J].Neurology,2001,56(2):215-219.
9Miller DH,Frank JA.Magnetic resonance imaging techiniques to monitor short term evolution of mutiple sclerosis and to use in preliminary trails[J].J Neurol Neurosurg Psychiatry,1998,64(suppl 1):44-46.
10Molyneux PD,Fillippi M,Barkholf F,et al.Correlations between monthly enhanced MRI lession rate and changes in T2 lession volume in mutiple sclerosis[J].Ann Neurol,1998,43(3):332-339.
5Brex PA,Miszkiel KA,O'Piordan JI,et al.Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes:the role of a follow up MRI[J].J Neurol Neurosurg Psychiat,1998;64 (suppl1):44-46
6Fischer JS,Rudick RA,Cutter GR,et al.The multiple sclerosis functional composite measure (MSFC):an integrated approach to MS clinical outcome assessment.National MS Society clinical outcomes assessment task force[J].Mult Scler,1999; 5(4):244-250
7Molyneux PD,Fillippi M,Barkholf F,et al.Correlations between monthly enhanced MRI lession rate and changes in T2 lession volume in multiple sclerosis[J].Ann Neurol,1998;43(3):332-339
8Nynke F,Kalkers,Najim Ameziane,et al.Longitudinal brain volume measurement in multiple sclerosis:rate of brain atrophy is independent of the disease subtype[J].Arch Neurol,2002; 59 (10):1572-1576
9Filippi M,Grossman RI.MRI techniques to monitor MS evolution[J].Neurology,2002; 58 (8):1147-1153
10Fisher E,Rudick RA,Simon JH,et al.Eight year follow up study of brain atrophy in patients with MS[J].Neurology,2002;59(9):1412-1420
